Target intelligence / Profile preview

Zinc finger protein 397 (ZNF397)

Target
ZNF397
Molecular classification
Transcription factor
01

Overview

Zinc finger protein 397 (ZNF397) is a human transcription factor containing a N-terminal SCAN domain and multiple C2H2-type zinc finger repeats, which allow it to bind DNA and participate in transcriptional regulation[2][3]. ZNF397 functions as a coactivator of the androgen receptor, playing an essential role in maintaining androgen receptor-driven luminal lineage programs in prostate tissue[1]. Loss of ZNF397 induces lineage plasticity in prostate cancer cells via a switch to TET2-dependent epigenetic programs, promoting resistance to androgen receptor-targeted therapies[1]. Although not a receptor, enzyme, or traditional therapeutic target, ZNF397 is a transcriptional regulator with emerging roles in cancer progression and therapy resistance[1][2][3]. No drugs are currently known to directly target ZNF397, but TET2 inhibitors can reverse resistance phenotypes associated with its loss in preclinical models[1].

Other names
ZNF47ZSCAN15MGC13250Zinc finger and SCAN domain-containing protein 15Zinc finger protein 47
02

Mechanism of action

Modulation of epigenetic state via regulation of androgen receptor-driven transcriptional programs and interaction with TET2-dependent pathways

03

Biological functions

Transcriptional regulationCoactivator of androgen receptorEpigenetic regulation
04

Disease associations

CancerProstate cancerDrug resistance
05

Safety considerations

Therapeutic modulation could theoretically impact lineage plasticity and tumor epigenetics, but direct safety data are lacking
06

Interacting drugs

TET2 inhibitors (e.g., molecules targeting TET2 in the context of resistance, not directly binding to ZNF397)
07

Biomarkers

ZNF397 loss (potential biomarker of resistance to androgen receptor-targeted therapy in prostate cancer)[1]

Beyond the preview

Go deeper on Zinc finger protein 397 (ZNF397).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 397 (ZNF397).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call